Effect of leukotriene inhibitor on otoacoustic emissions in salicylate ototoxicity

American Journal of Otology

Volumn 17, Issue 5, 1996, Pages 787-792

  Arruda, Johnny ^a   Jung, Timothy T K ^a,c   McGann, David G ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Leukotriene; Leukotriene blocker; Ototoxicity otoacoustic emission; Salicylate

Indexed keywords

1,2 DIHYDRO 4 HYDROXY 1 PHENYL 3 (1 PYRROLIDINYL) 1,8 NAPHTHYRIDIN 2 ONE; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; SALICYLATE SODIUM;

ANIMAL EXPERIMENT; ARTICLE; CHINCHILLA; CONTROLLED STUDY; EVOKED OTOACOUSTIC EMISSION; NONHUMAN; ORAL DRUG ADMINISTRATION; OTOTOXICITY; PRIORITY JOURNAL;

ACOUSTIC STIMULATION; ANIMALS; CHINCHILLA; COCHLEA; HAIR CELLS; LEUKOTRIENES; SALICYLATES;

EID: 0029797923     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bernstein JM, Weiss AD. Further observations on salicylate ototoxicity. J Laryngol Otol 1967;81:915-25.
2. DeMoura LF, Hayden RC. Salicylate ototoxicity. Arch Otolaryngol 1968;87:60-4.
3. Covell WP. A cytologic study of the effects of drugs on the cochlea. Arch Otolaryngol 1938;23:633-41.
4. Myers EN, Bernstein JM. Salicylate ototoxicity: a clinical and experimental study. Arch Otolaryngol 1965;82:483-93.
5. Deer BC, Hunter-Duvar I. Salicylate ototoxicity in the chinchilla: a behavioral and electron microscope study. J Otolaryngol 1982;11:260-4.
6. Silverstein H, Bernstein JM, Davies DG. Salicylate ototoxicity, a biochemical and electrophysiological study. Ann Otol Rhinol Laryngol 1967;76:118-28.
7. Ishii T, Bernstein JM, Balogh K. Distribution of tritium-labeled salicylate in the cochlea: an autoradiographic study. Ann Otol Rhinol Laryngol 1967;76:368-76.
8. Krzanowski J, Matschinsky F. A phosphocreatine gradient opposite to that of glycogen in the organ of Corti and the effect of salicylate on adenosine triphosphate and P-creatine in cochlear structures. J Histochem Cytochem 1971;19:321-3.
9. Jung TTK, Kim PS, Kim DH, Miller SK, Vasquez BJ. Effect of sodium salicylate on levels of catecholamines in the perilymph. Abst Assoc Res Otolaryngol 1990;13:52.
10. Cazals Y, Li X, Aurousseau C, Didier A. Acute effects of noradrenalin related vasoactive agents in the ototoxicity of aspirin: an experimental study in the guinea pig. Hear Res 1988;36:89-96.
11. Fratianni T, Jung TTK, Miller SK, Vasquez B. Effects of adrenergic blockers on sodium salicylate-induced ototoxicity. Otolaryngol Head Neck Surg 1990;103:233.
12. Gunther T, Rebentisch E, Vormann J. Enhanced ototoxicity of salicylate by magnesium deficiency. Magnes Bull 1989;11:15-18.
13. Gunther T, Rebentisch E, Vormann J. Protection against salicylate ototoxicity by zinc. J Trace Elem Electrolytes Health Dis 1989;3:51-3.
14. Jung TTK, Miller SK, Park YM, Woo HY, Baer W. Effect of nonsteroidal anti-inflammatory drugs on levels of lipoxygenase products in perilymph and hearing. Abstr Assoc Res Otolaryngol 1989;12:105.
15. Jung TTK, Miller SK, Rozehnal S, Woo HY, Park YM, Baer W. Effect of round window membrane application of salicylate and indomethacin on hearing and levels of arachidonic acid metabolites in perilymph. Acta Otolaryngol (Stockh) 1992;493:81-7.
16. Jung TTK, Park YM, Miller SK. Effect of lipoxygenase inhibitor (Sch. 37224) on hearing and perilymph levels of arachidonic acid metabolites in ototoxicity induced by sodium salicylate. Abstr Assoc Res Otolaryngol 1990;13:412.
17. Didier A, Nuttall AL, Miller JM. Sodium salicylate-induced blood flow changes and hearing losses in the guinea pig cochlea. Abstr Assoc Res Otolaryngol 1990;13:310.
18. Douek EE, Dodson HC, Bannister LH. The effects of sodium salicylate on the cochlea of guinea pigs. J Otol Laryngol 1983; 93:793-9.
19. Dieler R, Shehata-Dieler WE, Brownell WE. Concomitant salicylate-induced alterations of outer hair cell subsurface cisternae and electromotility. J Neurocytol 1991;20:637-53.
20. Brownell WE, Winston JB. Slow electrically evoked volume changes in guinea pig outer hair cells. Abstr Assoc Res Otolaryngol 1989;12:138.
21. Shehata WE, Brownell WE, Dieler R. Effects of salicylate on shape, electromotility and membrane characteristics of isolated outer hair cells from guinea pig cochlea. Acta Otolaryngol (Stockh) 1991;111:707-18.
22. McFadden D, Plattsmier HS. Aspirin abolishes spontaneous otoacoustic emissions. J Acoust Soc Am 1984;76:443-8.
23. Long GR, Tubis A. Modification of spontaneous and evoked otoacoustic emissions and associated psychoacoustic microstructure by aspirin consumption. J Acoust Soc Am 1988;84:1343-53.
24. Hauser R, Harris FP, Probst R, Frei F. Influence of general anesthesia on transiently evoked otoacoustic emissions in humans. Ann Otol Rhinol Laryngol 1992;101:994-9.
25. Jung TTK, Park YM, Miller SK, Rozehnal S, Woo HY, Baer W. Effect of exogenous arachidonic acid metabolites applied on round window membrane on hearing and their levels in the perilymph. Acta Otolaryngol (Stockh) 1992;493:171-6.
26. Jung TTK, Hwang AL, Miller SK, Rhee CK, Park YS. Effect of leukotriene inhibitor on cochlear blood flow in salicylate ototoxicity. Acta Otolaryngol (Stockh) 1995;115:251-4.
27. Kemp DT. Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am 1978;64:1386-91.
28. Wilson JP. Evidence for a cochlear origin for acoustic re-emissions, threshold fine-structure and tonal tinnitus. Hear Res 1980;2:233-52.
29. Brownell WE. Outer hair cell electromotility and otoacoustic emissions. Ear Hear 1990;11:82-92.
30. Mountain DC. Changes in endolymphatic potential and crossed olivocochlear bundle stimulation alter cochlear mechanics. Science 1980;210:71-2.
31. Siegel JH, Kim DO. Efferent neural control of cochlear mechanics? Olivocochlear bundle stimulation affects cochlear biomechanical nonlinearity. Hear Res 1982;6:171-82.
32. Jung TTK, Rhee CK, Lee CS, Park YS, Choi DC. Ototoxicity of salicylate, nonsteroidal anti-inflammatory drugs, and quinine. Otolaryngol Clin North Am 1993;26:791-810.